- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by BioNTech SE
Total 1829 results
-
BioNTech SERecruiting
-
BioNTech SERecruitingSolid TumorUnited States, Spain, Singapore, United Kingdom
-
BioNTech SERecruitingNon-Small Cell Lung CancerSpain, Germany, Turkey, United States, Hungary, United Kingdom, Poland
-
BioNTech SERecruiting
-
BioNTech SEActive, not recruitingSolid Tumor | Extensive-stage Small Cell Lung CancerUnited States, Spain, United Kingdom, Germany
-
BioNTech SEActive, not recruiting
-
BioNTech SETerminatedProstate CancerUnited States, Germany, United Kingdom, Hungary
-
BioNTech SECompletedCOVID-19 | SARS-CoV-2 InfectionGermany
-
BioNTech SERecruiting
-
BioNTech SERecruiting
-
BioNTech SERecruiting
-
BioNTech SERecruitingRecurrent Head and Neck Cancer | Unresectable Head and Neck Squamous Cell Carcinoma | Metastatic Head and Neck CancerGermany, United States, France, United Kingdom, Korea, Republic of, Spain, Poland, Belgium, Brazil, Taiwan, Italy, Canada, Czechia, Australia, Turkey, Mexico, Chile, Argentina, Austria, Hungary, Portugal, Sweden
-
BioNTech SECompletedCovid-19 | Protection Against COVID-19Germany
-
BioNTech SECompletedCOVID-19 | SARS-CoV2 Infection | SARS-CoV-2 Acute Respiratory Disease | SARS (Disease)United States, Germany, Turkey, South Africa
-
BioNTech SETerminatedGastric Cancer | Pancreatic Cancer | Solid Tumor | Metastatic Cancer | Cholangiocarcinoma | Esophageal Adenocarcinoma | Biliary Tract Cancer | Gastroesophageal Junction AdenocarcinomaUnited States, Canada
-
BioNTech SECompleted
-
BioNTech SEActive, not recruitingRNA Virus Infections | Virus Diseases | Vaccine Adverse Reaction | Infection Viral | Infections, Respiratory | Protection Against COVID-19 and Infections With SARS CoV 2Germany
-
BioNTech SERecruiting
-
BioNTech SERecruitingMonkeypoxUnited Kingdom, United States
-
BioNTech SERecruitingColorectal Cancer Stage II | Colorectal Cancer Stage IIIUnited States, Spain, Germany, Belgium
-
BioNTech SERecruitingColorectal Cancer Stage II | Colorectal Cancer Stage IIIUnited States, Spain, United Kingdom, Germany, Belgium, Sweden
-
BioNTech SEActive, not recruitingSolid TumorUnited States, Spain
-
BioNTech SEPfizerRecruiting
-
BioNTech SEPfizerActive, not recruitingCOVID-19 | SARS-CoV-2 InfectionUnited States
-
BioNTech SEPfizerCompletedSARS-CoV-2 Infection, COVID-19United States, Spain, Finland, Poland, Mexico, Brazil
-
BioNTech SEPfizerCompletedCOVID-19 | SARS-CoV-2 Infection | Maternal ImmunizationUnited States, United Kingdom, Spain, Brazil, South Africa
-
BioNTech SEPfizerCompletedCOVID-19 | SARS-CoV-2 InfectionUnited States, Brazil, South Africa, Germany, Canada, Israel
-
BioNTech SEPfizerCompletedCOVID-19 | SARS-CoV-2 InfectionJapan
-
BioNTech SEPfizerCompletedCOVID-19 | SARS-CoV-2 InfectionUnited States
-
BioNTech SEPfizerCompleted
-
BioNTech SEGenmabRecruitingAdvanced Malignant Solid TumorUnited States, United Kingdom
-
GenmabBioNTech SENot yet recruitingAdvanced Endometrial CancerKorea, Republic of, Spain, Belgium, United States, Denmark, Italy
-
GenmabBioNTech SEActive, not recruitingCervical Cancer | Squamous Cell Carcinoma of the Head and Neck | Triple Negative Breast Cancer | Non-small Cell Lung Cancer | Solid Tumors | Endometrial Carcinoma | Urothelial CarcinomaUnited States, Spain, Israel, Czechia, Georgia, Italy, Poland, Turkey, Hungary, Ukraine
-
BioNTech SEPfizerWithdrawn
-
BioNTech SEPfizerActive, not recruitingCOVID-19 | SARS-CoV-2 InfectionUnited States
-
BioNTech SEPfizerCompletedCOVID-19 | SARS-CoV-2 InfectionUnited States, Germany, Turkey, South Africa, Argentina, Brazil
-
BioNTech US Inc.RecruitingMetastatic Melanoma | Unresectable MelanomaBelgium, Netherlands, Spain
-
GenmabBioNTech SERecruitingMalignant Solid TumorJapan
-
BioNTech SEPfizerRecruitingCOVID-19 | Severe Acute Respiratory Syndrome Coronavirus 2 | SARS-CoV-2 VirusUnited States, Brazil, Puerto Rico
-
GenmabBioNTech SERecruiting
-
GenmabBioNTech SERecruitingMelanoma | Malignant Solid Tumor | Non Small Cell Lung Cancer (NSCLC) | Pancreatic Ductal Adenocarcinoma (PDAC) | Head and Neck Squamous Cell Carcinoma (HNSCC) | Colorectal Cancer (CRC)United States, Taiwan, Spain, Israel, Korea, Republic of, France, Italy, Denmark, Germany, United Kingdom, Georgia, Moldova, Republic of
-
BioNTech SEPfizerCompletedCOVID-19 | SARS-CoV-2 InfectionUnited States
-
GenmabBioNTech SEActive, not recruitingSolid Tumor, AdultSpain, Georgia, Moldova, Republic of
-
GenmabBioNTech SEActive, not recruitingSolid Tumor, AdultSpain, United States
-
GenmabBioNTech SEActive, not recruiting
-
BioNTech SEPfizerCompletedCOVID-19 | Influenza, HumanUnited States
-
BioNTech SEPfizerCompletedSARS-CoV-2 Infection, COVID19United States, Brazil, Germany, Mexico
-
BioNTech SEPfizerCompletedCOVID-19 | SARS-CoV-2 InfectionAustralia, New Zealand
-
BioNTech Research & Development, Inc.RecruitingPancreatic CancerUnited States
-
BioNTech RNA Pharmaceuticals GmbHCompleted